University Medical Center Groningen: Tuberculosis trials

The registry lists 13 Tuberculosis studies with University Medical Center Groningen as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 4Phase 4 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With TuberculosisRecruitingNCT07708779Phase 1
• Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis PatientsCompletedNCT01521364Phase 4Results posted
• Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™Status unknownNCT04249531Phase 1
• PCR Techniques of Dried Sputum Using a SpotcardStatus unknownNCT04055584
• Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis PatientsStatus unknownNCT03409315
• Azithromycin as Host-directed Therapy for Pulmonary TuberculosisCompletedNCT03160638Phase 2
• Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis DrugsCompletedNCT03080012
• PK of Levofloxacin in MDR-TB PatientsCompletedNCT03000517
• Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis PatientsCompletedNCT02169141
• HRZE Fasted/Fed in Newly Diagnosed TBCompletedNCT02121314Phase 2
• Pharmacokinetic Parameters of Co-trimoxazoleCompletedNCT01832987Phase 2
• PK/PD of Ertapenem In Patients With TBCompletedNCT01730664Phase 2
• Pharmacokinetics and Safety of MoxifloxacinTerminatedNCT01329250Phase 4